Date: Monday 15 Jun 2015
LONDON (ShareCast) - Circassia Pharmaceuticals has officially declared an unconditional offer for Aerocrine and extended its acceptance period until 26 June.
During the acceptance period, roughly 6.5m shares have been tendered, representing 93% of shared and voting rights in Aerocrine.
Circassia first made a public cash offer of 2.55 Swedish kroner per share for Aerocrine on 15 May, with the acceptance period ending 11 June.
As of 16:00 BST, Circassia was trading 1.1% higher at 284p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 74.00p |
Change Today | -1.00p |
% Change | -1.33 % |
52 Week High | 75.40 |
52 Week Low | 54.00 |
Volume | 162,974 |
Shares Issued | 422.05m |
Market Cap | £312.31m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 5 |
Latest | Previous | |
---|---|---|
Final | Special | |
Ex-Div | 23-May-24 | 17-Aug-23 |
Paid | 24-Jun-24 | 15-Sep-23 |
Amount | 1.00p | 2.50p |
Time | Volume / Share Price |
13:24 | 511 @ 74.00p |
13:24 | 45 @ 74.00p |
13:24 | 6,751 @ 74.00p |
13:22 | 340 @ 73.70p |
12:37 | 105 @ 73.40p |
You are here: research